Increased expression of ASAP1 was correlated with poor prognosis in head and neck squamous cell carcinoma [11,12], hepatocellular carcinoma [13], gastric cancer [14], epithelial ovarian cancer [15], clear cell renal cell carcinoma [16], and pancreatic cancer [17]. Here, ASAP1 is linked to hepatocellular carcinoma.